Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015 (2015), Article ID 270763, 9 pages
http://dx.doi.org/10.1155/2015/270763
Research Article

GDF15(MIC1) H6D Polymorphism Does Not Influence Cardiovascular Disease in a Latin American Population with Rheumatoid Arthritis

1Center for Autoimmune Diseases Research (CREA), School of Medicine and Health Sciences, Universidad del Rosario, Carrera 24 No. 63C-69, Bogotá, Colombia
2Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, 825 NE 13th Street, Oklahoma City, OK 73104, USA

Received 20 July 2014; Accepted 3 February 2015

Academic Editor: Mario Clerici

Copyright © 2015 Jenny Amaya-Amaya et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Sanmartí, V. Ruiz-Esquide, and M. V. Hernández, “Rheumatoid arthritis: a clinical overview of new diagnostic and treatment approaches,” Current Topics in Medicinal Chemistry, vol. 13, no. 6, pp. 698–704, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. D. L. Scott, F. Wolfe, and T. W. J. Huizinga, “Rheumatoid arthritis,” The Lancet, vol. 376, no. 9746, pp. 1094–1108, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. C. Barragán-Martínez, J. Amaya-Amaya, R. Pineda-Tamayo et al., “Gender differences in latin-american patients with rheumatoid arthritis,” Gender Medicine, vol. 9, no. 6, pp. 490.e5–510.e5, 2012. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Chopra, “The WHO ILAR COPCORD Latin America: consistent with the world and setting a new perspective,” Journal of Clinical Rheumatology, vol. 18, no. 4, pp. 167–169, 2012. View at Publisher · View at Google Scholar · View at Scopus
  5. O.-D. Ortega-Hernandez, R. Pineda-Tamayo, A. L. Pardo, A. Rojas-Villarraga, and J.-M. Anaya, “Cardiovascular disease is associated with extra-articular manifestations in patients with rheumatoid arthritis,” Clinical Rheumatology, vol. 28, no. 7, pp. 767–775, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. A. Rojas-Villarraga, O.-D. Ortega-Hernandez, L. F. Gomez et al., “Risk factors associated with different stages of atherosclerosis in Colombian patients with rheumatoid arthritis,” Seminars in Arthritis & Rheumatism, vol. 38, no. 2, pp. 71–82, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. J. Amaya-Amaya, J. C. Sarmiento-Monroy, R.-D. Mantilla, R. Pineda-Tamayo, A. Rojas-Villarraga, and J.-M. Anaya, “Novel risk factors for cardiovascular disease in rheumatoid arthritis,” Immunologic Research, vol. 56, no. 2-3, pp. 267–286, 2013. View at Publisher · View at Google Scholar · View at Scopus
  8. J. C. Sarmiento-Monroy, J. Amaya-Amaya, J. S. Espinosa-Serna, C. Herrera-Díaz, J.-M. Anaya, and A. Rojas-Villarraga, “Cardiovascular disease in rheumatoid arthritis: a systematic literature review in Latin America,” Arthritis, vol. 2012, Article ID 371909, 17 pages, 2012. View at Publisher · View at Google Scholar
  9. A. Sandoo, J. J. C. S. V. van Zanten, G. S. Metsios, D. Carroll, and G. D. Kitas, “Vascular function and morphology in rheumatoid arthritis: a systematic review,” Rheumatology (Oxford), vol. 50, no. 11, pp. 2125–2139, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. E. Gkaliagkousi, E. Gavriilaki, M. Doumas, K. Petidis, S. Aslanidis, and D. Stella, “Cardiovascular risk in rheumatoid arthritis: pathogenesis, diagnosis, and management,” Journal of Clinical Rheumatology, vol. 18, no. 8, pp. 422–430, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. L. Ärlestig and S. Rantapää-Dahlqvist, “Polymorphisms of the genes encoding CD40 and growth differentiation factor 15 and in the 9p21.3 region in patients with rheumatoid arthritis and cardiovascular disease,” Journal of Rheumatology, vol. 39, no. 5, pp. 939–945, 2012. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Unsicker, B. Spittau, and K. Krieglstein, “The multiple facets of the TGF-β family cytokine growth/differentiation factor-15/macrophage inhibitory cytokine-1,” Cytokine & Growth Factor Reviews, vol. 24, no. 4, pp. 373–384, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. R. S. Mehta, M. Song, N. Bezawada et al., “A Prospective study of macrophage inhibitory cytokine-1 (MIC-1/GDF15) and risk of colorectal cancer,” Journal of the National Cancer Institute, vol. 106, no. 4, Article ID dju016, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. D. A. Brown, J. Moore, H. Johnen et al., “Serum macrophage inhibitory cytokine 1 in rheumatoid arthritis: a potential marker of erosive joint destruction,” Arthritis & Rheumatism, vol. 56, no. 3, pp. 753–764, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. F. C. Arnett, S. M. Edworthy, D. A. Bloch et al., “The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis,” Arthritis and Rheumatism, vol. 31, no. 3, pp. 315–324, 1988. View at Publisher · View at Google Scholar · View at Scopus
  16. Law 115, General on Education, 8th February 1994.
  17. Law 30, General on Higher Education, p. 4, 1992.
  18. J. Cárdenas-Roldán, A. Rojas-Villarraga, and J.-M. Anaya, “How do autoimmune diseases cluster in families? A systematic review and meta-analysis,” BMC Medicine, vol. 11, no. 1, article 73, 2013. View at Publisher · View at Google Scholar · View at Scopus
  19. D. van der Heijde, “How to read radiographs according to the Sharp/van der Heijde method,” The Journal of Rheumatology, vol. 26, no. 3, pp. 743–745, 1999. View at Google Scholar · View at Scopus
  20. British Cardiac Society, British Hyperlipidaemia Association, British Hypertension Society, and British Diabetic Association, “Joint British recommendations on prevention of coronary heart disease in clinical practice: summary,” British Medical Journal, vol. 320, pp. 705–708, 2000. View at Publisher · View at Google Scholar
  21. P. G. Talwalkar, C. G. Sreenivas, A. Gulati, and H. Baxi, “Journey in guidelines for lipid management: from adult treatment panel (ATP)-I to ATP-III and what to expect in ATP-IV,” Indian Journal of Endocrinology and Metabolism, vol. 17, pp. 628–635, 2013. View at Google Scholar
  22. G. Veronesi, F. Gianfagna, S. Giampaoli et al., “Improving long-term prediction of first cardiovascular event: the contribution of family history of coronary heart disease and social status,” Preventive Medicine, vol. 64, pp. 75–80, 2014. View at Publisher · View at Google Scholar · View at Scopus
  23. B. A. Franklin, J. L. Durstine, C. K. Roberts, and R. J. Barnard, “Impact of diet and exercise on lipid management in the modern era,” Best Practice & Research: Clinical Endocrinology & Metabolism, vol. 28, no. 3, pp. 405–421, 2014. View at Publisher · View at Google Scholar · View at Scopus
  24. American Diabetes Association, “Standards of medical care in diabetes—2012,” Diabetes Care, vol. 35, supplement 1, pp. S11–S63, 2012. View at Publisher · View at Google Scholar
  25. Z. Reiner, A. L. Catapano, G. de Backer et al., “ESC/EAS guidelines for the management of dyslipidaemias: the task force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS),” European Heart Journal, vol. 32, no. 14, pp. 1769–1818, 2011. View at Publisher · View at Google Scholar
  26. D. W. Jones and J. E. Hall, “Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure and evidence from new hypertension trials,” Hypertension, vol. 43, no. 1, pp. 1–3, 2004. View at Publisher · View at Google Scholar · View at Scopus
  27. Y. Liao, S. Kwon, S. Shaughnessy et al., “Critical evaluation of adult treatment panel III criteria in identifying insulin resistance with dyslipidemia,” Diabetes Care, vol. 27, no. 4, pp. 978–983, 2004. View at Publisher · View at Google Scholar · View at Scopus
  28. S. Klein, D. B. Allison, S. B. Heymsfield et al., “Waist circumference and cardiometabolic risk: a consensus statement from shaping America's health: Association for weight management and obesity prevention; NAASO, the obesity society; the American society for nutrition; and the American diabetes association,” Obesity, vol. 15, no. 5, pp. 1061–1067, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. C. Day, “Metabolic syndrome, or what you will: definitions and epidemiology,” Diabetes & Vascular Disease Research, vol. 4, no. 1, pp. 32–38, 2007. View at Publisher · View at Google Scholar
  30. P. C. Deedwania, K. C. Maki, M. R. Dicklin, N. J. Stone, C. M. Ballantyne, and M. H. Davidson, “Application of recent definitions of the metabolic syndrome to survey data from the National Cholesterol Education Program Evaluation Project Utilizing Novel E-Technology (NEPTUNE II),” Journal of the CardioMetabolic Syndrome, vol. 1, no. 5, pp. 295–300, 2006. View at Publisher · View at Google Scholar · View at Scopus
  31. I. Wendelhag, O. Wiklund, and J. Wikstrand, “Arterial wall thickness in familial hypercholesterolemia: ultrasound measurement of intima-media thickness in the common carotid artery,” Arteriosclerosis and Thrombosis, vol. 12, no. 1, pp. 70–77, 1992. View at Publisher · View at Google Scholar · View at Scopus
  32. R. Salonen and J. T. Salonen, “Determinants of carotid intima-media thickness: a population-based ultrasonography study in Eastern Finnish men,” Journal of Internal Medicine, vol. 229, no. 3, pp. 225–231, 1991. View at Publisher · View at Google Scholar · View at Scopus
  33. P. Pignoli, E. Tremoli, A. Poli, P. Oreste, and R. Paoletti, “Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging,” Circulation, vol. 74, no. 6, pp. 1399–1406, 1986. View at Publisher · View at Google Scholar · View at Scopus
  34. G. Mancia, G. de Backer, A. Dominiczak et al., “2007 guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC),” European Heart Journal, vol. 28, pp. 1462–1536, 2007. View at Google Scholar
  35. L. Morineau, A. Lebart, and M. Piron, Statistique Exploratoire Multidimensionnelle, Dunod, Paris, France, 1995.
  36. R Development Core Team, R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing, Vienna, Austria, 2013.
  37. M. A. Gonzalez-Gay, C. Garcia-Porrua, and A. H. Hajeer, “Influence of human leukocyte antigen-DRB1 on the susceptibility and severity of rheumatoid arthritis,” Seminars in Arthritis and Rheumatism, vol. 31, no. 6, pp. 355–360, 2002. View at Publisher · View at Google Scholar · View at Scopus
  38. E. W. Karlson, L. B. Chibnik, J. Cui et al., “Associations between Human leukocyte antigen, PTPN22, CTLA4 genotypes and rheumatoid arthritis phenotypes of autoantibody status, age at diagnosis and erosions in a large cohort study,” Annals of the Rheumatic Diseases, vol. 67, no. 3, pp. 358–363, 2008. View at Publisher · View at Google Scholar · View at Scopus
  39. C. Auffray, D. Charron, and L. Hood, “Predictive, preventive, personalized and participatory medicine: back to the future,” Genome Medicine, vol. 2, no. 8, article 57, 2010. View at Publisher · View at Google Scholar · View at Scopus